Swiss pharmaceutical giant Roche (RHHBY) has agreed to acquire U.S. biotech company 89bio (ETNB) for a price of up to $3.5 billion, including contingent payments. ETNB stock jumped 83% in Thursday’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback